書籍情報から探す
QT PRODACT：Database Construction for the Evaluation of the Risk of QT Interval Prolongation by Drugs in Japan
Haruaki Nakaya1, Keitaro Hashimoto2
1Department of Pharmacology, Chiba University Graduate School of Medicine, 2Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi
Journal of Pharmacological Sciences 99 (5) 421-421, 2005.
1Department of Pharmacology, Chiba University Graduate School of Medicine, 2Department of Pharmacology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi
Journal of Pharmacological Sciences 99 (5) 421-421, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
Preface
Keiji Yamamoto
QT PRODACT
Journal of Pharmacological Sciences 99 (5) 422-422, 2005.
QT PRODACT
Journal of Pharmacological Sciences 99 (5) 422-422, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
QT PRODACT：A Multi-site Study of In Vitro Action Potential Assays on 21 Compounds in Isolated Guinea-Pig Papillary Muscles
Seiji Hayashi1, 2, Yoshihide Kii1, 3, Mitsuyasu Tabo1, 4, Hitoshi Fukuda1, 5, Tetsuji Itoh1, 6, Takashi Shimosato1, 7, Hideto Amano1, 8, Mamoru Saito1, 9, Hajime Morimoto1, 10, Kiyoshi Yamada1, 11, Atsuhiro Kanda1, 12, Toshimasa Ishitsuka1, 13, Takanobu Yamazaki1, 14, Yoichi Kiuchi1, 15, Shinya Taniguchi1, 16, Tatsuya Mori1, 17, Shigekazu Shimizu1, 18, Yuji Tsurubuchi1, 19, Shun-ichi Yasuda1, 20, Shin-ichi Kitani1, 21, Chiaki Shimada1, 22, Kazuo Kobayashi1, 23, Masaharu Komeno1, 24, Chieko Kasai1, 25, Toshiyasu Hombo1, 25, Keiji Yamamoto1, 26
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 3Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 4Safety Assessment Department, Chugai Pharmaceutical Co., Ltd., 5Research Laboratories, Toyama Chemical Co., Ltd., 6Developmental Research Laboratories, Shionogi & Co., Ltd., 7Research Department, NISSEI BILLS Co., Ltd., 8Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 9Drug Safety Research Laboratories, Eisai Co., Ltd., 10Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 11Pharmaceutical Research Laboratories, Toray Industries, Inc., 12Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd., 13Toxicology Laboratory, Mitsubishi Pharma Corporation, 14Research Center, Kyorin Pharmaceutical Co., Ltd., 15Medicinal Development Research Laboratories, Taisho Pharmaceutical Co., Ltd., 16Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., 17Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 18Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 19Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 20Study Department, Nihon Bioresearch Inc., 21Pharmacology & Toxicology Department, Ina Research, Inc., 22Research and Development Center, Fuso Pharmaceutical Industries, Ltd., 23Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., 24Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., 25Drug Safety Research Laboratories, Astellas Pharma Inc., 26Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 423-437, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 3Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 4Safety Assessment Department, Chugai Pharmaceutical Co., Ltd., 5Research Laboratories, Toyama Chemical Co., Ltd., 6Developmental Research Laboratories, Shionogi & Co., Ltd., 7Research Department, NISSEI BILLS Co., Ltd., 8Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 9Drug Safety Research Laboratories, Eisai Co., Ltd., 10Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 11Pharmaceutical Research Laboratories, Toray Industries, Inc., 12Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd., 13Toxicology Laboratory, Mitsubishi Pharma Corporation, 14Research Center, Kyorin Pharmaceutical Co., Ltd., 15Medicinal Development Research Laboratories, Taisho Pharmaceutical Co., Ltd., 16Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., 17Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 18Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 19Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 20Study Department, Nihon Bioresearch Inc., 21Pharmacology & Toxicology Department, Ina Research, Inc., 22Research and Development Center, Fuso Pharmaceutical Industries, Ltd., 23Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., 24Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., 25Drug Safety Research Laboratories, Astellas Pharma Inc., 26Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 423-437, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：Inter and Intra-facility Variability of the Action Potential Assay Using Isolated Guinea-Pig Papillary Muscles
Ryuzaburo Yamazaki1, 3, Masayuki Yamada1, 4, Kazuo Kobayashi1, 5, Shin-ichi Kitani1, 6, Chiaki Shimada1, 7, Takashi Shimosato1, 8, Tatsuya Mori1, 9, Hideki Suganami2, 10, Keiji Yamamoto1, 11
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Japan Pharmaceutical Manufacturers Association (JPMA), Biostatistics and Data Management Subcommittee, 3Non-Clinical Quality Assurance Section, Taisho Pharmaceutical Co., Ltd., 4Clinical Data & Development Management, Planning & Management Department, Kissei Pharmaceutical Co., Ltd., 5Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., 6Research Administration Department, Ina Research, Inc., 7Research & Development Center, Fuso Pharmaceutical Industries, Ltd., 8Research Department, NISSEI BILLS Co., Ltd., 9Toxicological Research Laboratories, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., 10Biostatistics and Data Management Department, Kowa Co., Ltd., 11Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 439-447, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Japan Pharmaceutical Manufacturers Association (JPMA), Biostatistics and Data Management Subcommittee, 3Non-Clinical Quality Assurance Section, Taisho Pharmaceutical Co., Ltd., 4Clinical Data & Development Management, Planning & Management Department, Kissei Pharmaceutical Co., Ltd., 5Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., 6Research Administration Department, Ina Research, Inc., 7Research & Development Center, Fuso Pharmaceutical Industries, Ltd., 8Research Department, NISSEI BILLS Co., Ltd., 9Toxicological Research Laboratories, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., 10Biostatistics and Data Management Department, Kowa Co., Ltd., 11Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 439-447, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：Evaluation of the Potential of Compounds to Cause QT Interval Prolongation by Action Potential Assays Using Guinea-Pig Papillary Muscles
Yoshihide Kii1, 2, Seiji Hayashi1, 3, Mitsuyasu Tabo1, 4, Takashi Shimosato1, 5, Hitoshi Fukuda1, 6, Tetsuji Itoh1, 7, Hideto Amano1, 8, Mamoru Saito1, 9, Hajime Morimoto1, 10, Kiyoshi Yamada1, 11, Atsuhiro Kanda1, 12, Toshimasa Ishitsuka1, 13, Takanobu Yamazak1, 14, Yoichi Kiuchi1, 15, Shinya Taniguchi1, 16, Tatsuya Mori1, 17, Shigekazu Shimizu1, 18, Yuji Tsurubuchi1, 19, Shun-ichi Yasuda1, 20, Shin-ichi Kitani1, 21, Chiaki Shimada1, 22, Kazuo Kobayashi1, 23, Masaharu Komeno1, 24, Chieko Kasai1, 25, Toshiyasu Hombo1, 25, Keiji Yamamoto1, 26
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 3Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 4Safety Assessment Department, Chugai Pharmaceutical Co., Ltd., 5Research Department, NISSEI BILLS Co., Ltd., 6Research Laboratories, Toyama Chemical Co., Ltd., 7Developmental Research Laboratories, Shionogi & Co., Ltd., 8Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 9Drug Safety Research Laboratories, Eisai Co., Ltd., 10Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 11Pharmaceutical Research Laboratories, Toray Industries, Inc., 12Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd., 13Toxicology Laboratory, Mitsubishi Pharma Corporation, 14Research Center, Kyorin Pharmaceutical Co., Ltd., 15Medicinal Development Research Laboratories, Taisho Pharmaceutical Co., Ltd., 16Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., 17Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 18Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 19Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 20Study Department, Nihon Bioresearch Inc., 21Pharmacology & Toxicology Department, Ina Research, Inc., 22Research and Development Center, Fuso Pharmaceutical Industries, Ltd., 23Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., 24Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., 25Drug Safety Research, Astellas Pharma Inc., 26Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 449-457, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 3Discovery Research Laboratories, Nippon Shinyaku Co., Ltd., 4Safety Assessment Department, Chugai Pharmaceutical Co., Ltd., 5Research Department, NISSEI BILLS Co., Ltd., 6Research Laboratories, Toyama Chemical Co., Ltd., 7Developmental Research Laboratories, Shionogi & Co., Ltd., 8Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 9Drug Safety Research Laboratories, Eisai Co., Ltd., 10Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 11Pharmaceutical Research Laboratories, Toray Industries, Inc., 12Pharmacobioregulation Research Laboratory, Taiho Pharmaceutical Co., Ltd., 13Toxicology Laboratory, Mitsubishi Pharma Corporation, 14Research Center, Kyorin Pharmaceutical Co., Ltd., 15Medicinal Development Research Laboratories, Taisho Pharmaceutical Co., Ltd., 16Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., 17Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 18Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 19Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 20Study Department, Nihon Bioresearch Inc., 21Pharmacology & Toxicology Department, Ina Research, Inc., 22Research and Development Center, Fuso Pharmaceutical Industries, Ltd., 23Pharmacodynamics Research Laboratories, Sankyo Co., Ltd., 24Fukui Safety Research Laboratories, Ono Pharmaceutical Co., Ltd., 25Drug Safety Research, Astellas Pharma Inc., 26Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 449-457, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：In Vivo QT Assay in the Conscious Dog for Assessing the Potential for QT Interval Prolongation by Human Pharmaceuticals
Shigeki Toyoshima1, 2, Akihiro Kanno1, 3, Tetsuya Kitayama1, 4, Koji Sekiya1, 5, Keiko Nakai1, 6, Masao Haruna1, 7, Terumasa Mino1, 8, Hiroyasu Miyazaki1, 9, Koji Yano1, 10, Keiji Yamamoto1, 11
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Division of Pharmacology, Drug Safety and Metabolism, Otsuka Pharmaceutical Factory, Inc., 3Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 4Pharmaceutical Research Center Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 5Pharmacology & Toxicology Department, Ina Research, Inc., 6Analysis and Metabolism Division, Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 7Developmental Research Laboratories, Shionogi & Co., Ltd., 8Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 9Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Co., Ltd., 10Drug Safety Research Laboratories, Tanabe Seiyaku Co., Ltd., 11Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 459-471, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Division of Pharmacology, Drug Safety and Metabolism, Otsuka Pharmaceutical Factory, Inc., 3Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 4Pharmaceutical Research Center Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 5Pharmacology & Toxicology Department, Ina Research, Inc., 6Analysis and Metabolism Division, Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 7Developmental Research Laboratories, Shionogi & Co., Ltd., 8Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 9Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Co., Ltd., 10Drug Safety Research Laboratories, Tanabe Seiyaku Co., Ltd., 11Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 459-471, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：In Vivo QT Assay in Anesthetized Dog for Detecting the Potential for QT Interval Prolongation by Human Pharmaceuticals
Hiroyuki Tashibu1, 2, Hiroyasu Miyazaki1, 3, Kumiko Aoki1, 4, Yasuki Akie1, 5, Keiji Yamamoto1, 6
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 3Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Co., Ltd., 4Pharmacology & Safety Research Department, Teijin Pharma Ltd., 5Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 6Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 473-486, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Safety Research Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 3Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Co., Ltd., 4Pharmacology & Safety Research Department, Teijin Pharma Ltd., 5Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 6Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 473-486, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：In Vivo QT Assay With a Conscious Monkey for Assessment of the Potential for Drug-Induced QT Interval Prolongation
Kentaro Ando1, 2, 9, Toshiyasu Hombo1, 3, Akihiro Kanno4, Hironobu Ikeda5, Masakazu Imaizumi6, Noritsugu Shimizu7, Kengo Sakamoto8, Shin-ichi Kitani8, Yoshinori Yamamoto9, Shingo Hizume9, Keiko Nakai9, Tetsuya Kitayama1, 10, Keiji Yamamoto1, 11
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Toxicology Laboratory, Mitsubishi Pharma Corporation, 3Drug Safety Research Laboratories, Astellas Pharma Inc., 4Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 5Research Department, NISSEI BILLS Co., Ltd., 6Department of Pharmacology, Panapharm Laboratories Co., Ltd., 7Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 8Pharmacology & Toxicology Department, Ina Research, Inc., 9Pharmacology Division, Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 10Toxicological Research Laboratories, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., 11Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 487-500, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Toxicology Laboratory, Mitsubishi Pharma Corporation, 3Drug Safety Research Laboratories, Astellas Pharma Inc., 4Pharmacological Research Laboratories, Drug Safety Testing Center Co., Ltd., 5Research Department, NISSEI BILLS Co., Ltd., 6Department of Pharmacology, Panapharm Laboratories Co., Ltd., 7Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 8Pharmacology & Toxicology Department, Ina Research, Inc., 9Pharmacology Division, Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., 10Toxicological Research Laboratories, Pharmaceutical Research Center, Kyowa Hakko Kogyo Co., Ltd., 11Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 487-500, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：Usability of Miniature Pigs in Safety Pharmacology Studies：Assessment for Drug-Induced QT Interval Prolongation
Mayumi Kano1, 2, Tohru Toyoshi1, 2, Sakae Iwasaki2, Masami Kato2, Masayoshi Shimizu2, Takao Ota2
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Study Department, Nihon Bioresearch Inc.,
Journal of Pharmacological Sciences 99 (5) 501-511, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Study Department, Nihon Bioresearch Inc.,
Journal of Pharmacological Sciences 99 (5) 501-511, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：Inter-facility Variability in Electrocardiographic and Hemodynamic Parameters in Conscious Dogs and Monkeys
Hiroyuki Sasaki1, 2, Noritsugu Shimizu3, Hideki Suganami1, 4, Keiji Yamamoto1, 5
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Research Department, Saitama Daiichi Pharmaceutical Co., Ltd., 3Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 4Biostatistics and Data Management Department, Kowa Co., Ltd., 5Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 513-522, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Research Department, Saitama Daiichi Pharmaceutical Co., Ltd., 3Kobuchisawa Laboratories, Fuji Biomedix Co., Ltd., 4Biostatistics and Data Management Department, Kowa Co., Ltd., 5Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 513-522, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：Sensitivity and Specificity of the Canine Telemetry Assay for Detecting Drug-Induced QT Interval Prolongation
Hiroyasu Miyazaki1, 2, Hiroyuki Watanabe1, 3, Tetsuya Kitayama1, 4, Masahiro Nishida1, 2, Yasuhiro Nishi1, 2, Koji Sekiya1, 5, Hideki Suganami1, 6, Keiji Yamamoto1, 7
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Co., Ltd., 3Biostatistics, Banyu Pharmaceutical Co., Ltd., 4Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 5Pharmacology & Toxicology Department, Ina Research, Inc.,, 6Data Management & Biostatistics, Kowa Co., Ltd., 7Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 523-529, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Tsukuba Safety Assessment Laboratories, Banyu Pharmaceutical Co., Ltd., 3Biostatistics, Banyu Pharmaceutical Co., Ltd., 4Toxicological Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., 5Pharmacology & Toxicology Department, Ina Research, Inc.,, 6Data Management & Biostatistics, Kowa Co., Ltd., 7Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 523-529, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
QT PRODACT：Comparison of Non-clinical Studies for Drug-Induced Delay in Ventricular Repolarization and Their Role in Safety Evaluation in Humans
Takeshi Omata1, 2, Chieko Kasai1, 3, Munehiro Hashimoto1, 4, Toshiyasu Hombo1, 5, Keiji Yamamoto1, 6
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 3Drug Safety Research Laboratories, Astellas Pharma Inc., 4Nonclinical Regulatory Sciences, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5Drug Safety Research Laboratories, Astellas Pharma Inc., 6Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 531-541, 2005.
1Japan Pharmaceutical Manufacturers Association (JPMA)/QT PRODACT, 2Central Research Laboratories, ZERIA Pharmaceutical Co., Ltd., 3Drug Safety Research Laboratories, Astellas Pharma Inc., 4Nonclinical Regulatory Sciences, Worldwide Safety Sciences, Global Research & Development, Nagoya Laboratories, Pfizer Japan Inc., 5Drug Safety Research Laboratories, Astellas Pharma Inc., 6Development Research Center, Takeda Pharmaceutical Co., Ltd.
Journal of Pharmacological Sciences 99 (5) 531-541, 2005.
- アブストラクト： 従量制は110円（税込）、基本料金制は基本料金に含まれます。
- 全文ダウンロード： 従量制、基本料金制の方共に770円(税込) です。
